Last reviewed · How we verify
Attenuated HAV Vaccine, H2 Strain — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Attenuated HAV Vaccine, H2 Strain (Attenuated HAV Vaccine, H2 Strain) — Institute of Medical Biology, Chinese Academy of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Attenuated HAV Vaccine, H2 Strain TARGET | Attenuated HAV Vaccine, H2 Strain | Institute of Medical Biology, Chinese Academy of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Attenuated HAV Vaccine, H2 Strain CI watch — RSS
- Attenuated HAV Vaccine, H2 Strain CI watch — Atom
- Attenuated HAV Vaccine, H2 Strain CI watch — JSON
- Attenuated HAV Vaccine, H2 Strain alone — RSS
Cite this brief
Drug Landscape (2026). Attenuated HAV Vaccine, H2 Strain — Competitive Intelligence Brief. https://druglandscape.com/ci/attenuated-hav-vaccine-h2-strain. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab